about
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits f...
Read More
46.50
1.17
(2.58%)
7.3M
XNAS Volume
High volume today
XNAS 05 Sep, 2025 5:30 PM (EDT)
High Financial Strength
Affordable Valuation
Technically Bearish
Value Stock, Under Radar
These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum.
View Similar
Embed DVM
Sanofi - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..